NDRA
Income statement / Annual
Last year (2025), ENDRA Life Sciences Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, ENDRA Life Sciences Inc's net income was -$7.03 M.
See ENDRA Life Sciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$6.17 K |
$351.62 K |
$515.58 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$172.78 K
|
$235.88 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.17 K
|
$178.84 K
|
$279.70 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0.51
|
0.54
|
| Research and Development Expenses |
$1.85 M
|
$3.19 M
|
$5.00 M
|
$6.55 M
|
$5.48 M
|
$5.92 M
|
$6.57 M
|
$4.72 M
|
$1.93 M
|
$495.38 K
|
| General & Administrative Expenses |
$3.72 M
|
$7.06 M
|
$4.70 M
|
$5.17 M
|
$4.94 M
|
$5.00 M
|
$3.86 M
|
$3.75 M
|
$2.75 M
|
$1.54 M
|
| Selling & Marketing Expenses |
$189.47 K
|
$571.04 K
|
$820.55 K
|
$1.43 M
|
$1.08 M
|
$581.89 K
|
$412.43 K
|
$262.64 K
|
$122.60 K
|
$34.13 K
|
| Selling, General & Administrative Expenses |
$3.91 M
|
$7.63 M
|
$5.52 M
|
$6.60 M
|
$6.02 M
|
$5.58 M
|
$4.27 M
|
$4.02 M
|
$2.87 M
|
$1.58 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$8.84 K
|
-$106.90 K
|
$287.54 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.76 M
|
$10.82 M
|
$10.52 M
|
$13.16 M
|
$11.50 M
|
$11.50 M
|
$10.84 M
|
$9.03 M
|
$4.80 M
|
$2.07 M
|
| Cost And Expenses |
$5.76 M
|
$10.82 M
|
$10.52 M
|
$13.16 M
|
$11.50 M
|
$11.50 M
|
$10.84 M
|
$9.03 M
|
$4.98 M
|
$2.31 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$232.43
|
$2.36 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$21.53 K
|
$0.00
|
$232.43 K
|
$2.36 M
|
$729.24 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$157.29 K
|
$206.17 K
|
$275.45 K
|
$234.26 K
|
$224.42 K
|
$165.25 K
|
$115.01 K
|
$68.32 K
|
$61.48 K
|
$64.94 K
|
| EBITDA |
-$6.87 M |
-$11.30 M |
-$9.78 M |
-$12.92 M |
-$11.01 M |
-$11.33 M |
-$10.84 M |
-$9.00 M |
-$4.56 M |
-$1.73 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-1457.52
|
-12.98
|
-3.35
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-1460.8
|
-13.16
|
-3.48
|
| Total Other Income/Expenses Net |
-$1.26 M
|
-$690.80 K
|
$460.49 K
|
-$21.53 K
|
$267.06 K
|
-$223.58 K
|
-$2.46 M
|
-$777.25 K
|
-$750.90 K
|
-$983.61 K
|
| Income Before Tax |
-$7.03 M
|
-$11.51 M
|
-$10.06 M
|
-$13.18 M
|
-$11.23 M
|
-$11.73 M
|
-$13.31 M
|
-$9.80 M
|
-$5.38 M
|
-$2.78 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-1586.7
|
-15.29
|
-5.38
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$7.03 M
|
-$11.51 M
|
-$10.06 M
|
-$13.18 M
|
-$11.23 M
|
-$11.73 M
|
-$13.31 M
|
-$9.80 M
|
-$5.38 M
|
-$2.78 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-1586.7
|
-15.29
|
-5.38
|
| EPS |
-8.93 |
-10.25 |
-5.89 |
-4.57 |
-5.47 |
-12.47 |
-41.48 |
-43.49 |
-27.47 |
-14.21 |
| EPS Diluted |
-8.93 |
-10.25 |
-5.89 |
-6.84 |
-5.47 |
-12.47 |
-41.48 |
-43.49 |
-27.47 |
-14.21 |
| Weighted Average Shares Out |
$787.02 K
|
$1.12 M
|
$1.71 M
|
$1.93 M
|
$2.05 M
|
$959.61 K
|
$375.00 K
|
$225.24 K
|
$195.75 K
|
$195.35 K
|
| Weighted Average Shares Out Diluted |
$787.02 K
|
$1.12 M
|
$1.71 M
|
$1.93 M
|
$2.05 M
|
$959.61 K
|
$375.00 K
|
$225.24 K
|
$195.75 K
|
$195.35 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
